Lamothe Jeffrey G.

CIK 00016799671 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001679967

Recent Transactions

50 trades

Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-08-08−272→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-08-08−42→ 41 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2024-08-08+42→ 894 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2024-08-08+272→ 1,166 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-07-17+12,825→ 12,825 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2024-03-03+3,667→ 37,504 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-03-03−3,667→ 3,667 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-03-02−5,500→ 11,000 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2024-03-02+5,500→ 33,837 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2024-01-28+1,833→ 28,337 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2024-01-28−1,833→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2023-08-08+11,979→ 24,671 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2023-08-08+1,833→ 26,504 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-08-08−1,833→ 3,667 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-08-08−11,979→ 11,979 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2023-03-03+16,500→ 16,500 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-03-03+16,500→ 16,500 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2023-03-03+3,666→ 12,692 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-03-03−3,666→ 7,334 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2023-01-29−1,834→ 1,833 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2023-01-29+1,834→ 9,026 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2022-08-09+5,500→ 5,500 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2022-08-09+5,500→ 5,500 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2022-08-09+23,958→ 23,958 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2022-06-07+11,000→ 11,000 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2022-03-04+11,000→ 11,000 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2022-01-29+1,833→ 3,667 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2022-01-29+1,833→ 7,192 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2021-01-29+16,500→ 16,500 total
Award
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2021-01-29+5,500→ 5,500 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−2,407→ 0 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−2,407→ 0 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−2,695→ 0 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27+7,380→ 7,380 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−3,128→ 0 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−4,814→ 0 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−4,814→ 0 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27+2,140→ 2,140 total
Disposition to Issuer
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-07-27−1,928→ 0 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2020-02-18+134,800→ 134,800 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2019-11-01+135,384→ 135,384 total
Tax Payment
Aptevo Therapeutics Inc.$APVO
Common Stock
2019-03-01$1.57/sh−2,170→ 75,024 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2019-03-01−7,318→ 0 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2019-03-01+7,318→ 77,194 total
Award
Aptevo Therapeutics Inc.$APVO
Stock Option (right to buy)
2019-02-28+67,400→ 67,400 total
Tax Payment
Aptevo Therapeutics Inc.$APVO
Common Stock
2018-03-10$3.13/sh−1,583→ 69,876 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2018-03-10−6,747→ 7,318 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Common Stock
2018-03-10+6,747→ 71,459 total
Award
Aptevo Therapeutics Inc.$APVO
Employee Stock Options (Right to Buy)
2018-03-09+67,400→ 67,400 total
Exercise/Conversion
Aptevo Therapeutics Inc.$APVO
Restricted Stock Unit
2018-03-01−7,320→ 14,065 total

Companies

Aptevo Therapeutics Inc.
SVP, CFO and Treasurer
$APVO

Recent Filings

Address

2401 4TH AVENUE, SUITE 1050

SEATTLE, WA, 98121

View on SEC.gov